MRI/MRS in neuroinflammation: methodology and applications
暂无分享,去创建一个
[1] Bruce R. Rosen,et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28 , 2015, NeuroImage: Clinical.
[2] Aaron J. Johnson,et al. In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] Ben A. Duffy,et al. Imaging seizure-induced inflammation using an antibody targeted iron oxide contrast agent , 2012, NeuroImage.
[4] P. Styles,et al. Hypo‐osmotic swelling‐activated release of organic osmolytes in brain slices: implications for brain oedema in vivo , 2001, Journal of neurochemistry.
[5] M. Rausch,et al. In‐vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO , 2002, NMR in biomedicine.
[6] Andreas Saleh,et al. In vivo MRI of brain in ̄ ammation in human ischaemic stroke , 2004 .
[7] D. Leibfritz,et al. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.
[8] N. Sibson,et al. VCAM‐1‐targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] Brian K Rutt,et al. Detection threshold of single SPIO‐labeled cells with FIESTA , 2005, Magnetic resonance in medicine.
[10] M. Inglese,et al. Diffusion imaging in multiple sclerosis: research and clinical implications , 2010 .
[11] J. Smirniotopoulos,et al. Patterns of contrast enhancement in the brain and meninges. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.
[12] J. Bernarding,et al. Metabolic changes in the vicinity of brain contusions: a proton magnetic resonance spectroscopy and histology study. , 2003, Journal of neurotrauma.
[13] Ting-Yim Lee,et al. An Adiabatic Approximation to the Tissue Homogeneity Model for Water Exchange in the Brain: I. Theoretical Derivation , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] R. Ransohoff,et al. Inflammatory cell trafficking across the blood–brain barrier: chemokine regulation and in vitro models , 2012, Immunological reviews.
[15] T. Koh,et al. Phenotypic transitions of macrophages orchestrate tissue repair. , 2013, The American journal of pathology.
[16] G. Réus,et al. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders , 2015, Neuroscience.
[17] S. Dhaliwal,et al. Blood–brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment , 2015, Immunity & Ageing.
[18] H. Critchley,et al. Quantitative Magnetization Transfer Imaging as a Biomarker for Effects of Systemic Inflammation on the Brain , 2015, Biological Psychiatry.
[19] Tilman Grune,et al. Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. , 2004, Free radical biology & medicine.
[20] E. Lo,et al. Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation , 2002, Progress in Neurobiology.
[21] J. Sandkühler,et al. Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity , 2013, Nature Reviews Neuroscience.
[22] N. Intrator,et al. Free water elimination and mapping from diffusion MRI , 2009, Magnetic resonance in medicine.
[23] Jurgen E Schneider,et al. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide , 2007, Nature Medicine.
[24] L. Kappos,et al. MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice , 2010, American Journal of Neuroradiology.
[25] Grace Hu,et al. Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles , 2005, Magnetic resonance in medicine.
[26] L. Steinman. Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab , 2005, Nature Reviews Drug Discovery.
[27] D. Le Bihan,et al. Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.
[28] Shigeru Furui,et al. Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy. , 2015, Radiology.
[29] H. Petropoulos,et al. Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study. , 2000, Journal of neurotrauma.
[30] T. Patterson,et al. Elevated myo-inositol in gray matter of recently detoxified but not long-term abstinent alcoholics: a preliminary MR spectroscopy study. , 2000, Alcoholism, clinical and experimental research.
[31] R. Lucht,et al. Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series , 2004, Magnetic resonance in medicine.
[32] Joanna M. Wardlaw,et al. Assessment of blood–brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review , 2014, NeuroImage: Clinical.
[33] A. Thompson,et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.
[34] R. Henkelman,et al. Magnetization transfer in MRI: a review , 2001, NMR in biomedicine.
[35] V. Perry,et al. Detection of the inhibitory neurotransmitter GABA in macrophages by magnetic resonance spectroscopy , 2005, Journal of leukocyte biology.
[36] Frederik Barkhof,et al. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. , 2008, Brain : a journal of neurology.
[37] Carl-Fredrik Westin,et al. The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia , 2015, Schizophrenia Research.
[38] C Delalande,et al. Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. , 1999, AJNR. American journal of neuroradiology.
[39] M. Yamada,et al. Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia , 2003, Neuroscience.
[40] B. Tombach,et al. Hepatic MRI with SPIO: detection and characterization of focal liver lesions , 1998, European Radiology.
[41] A. Wong,et al. Assessment of vessel permeability by combining dynamic contrast‐enhanced and arterial spin labeling MRI , 2015, NMR in biomedicine.
[42] Richard C. Semelka,et al. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents. , 2015, Radiology.
[43] Atle Bjørnerud,et al. The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system , 2004, NMR in biomedicine.
[44] Joanna Wardlaw,et al. Blood–brain barrier permeability in Alzheimer's disease: a case–control MRI study , 2009, Psychiatry Research: Neuroimaging.
[45] P. Basser,et al. Diffusion tensor MR imaging of the human brain. , 1996, Radiology.
[46] E. Akbudak,et al. Encoding of anisotropic diffusion with tetrahedral gradients: A general mathematical diffusion formalism and experimental results , 1996, Magnetic resonance in medicine.
[47] W. Rooney,et al. MR Imaging of Inflammation during Myelin-Specific T Cell-Mediated Autoimmune Attack in the EAE Mouse Spinal Cord , 2010, Molecular Imaging and Biology.
[48] S. Pluchino,et al. The role of the immune system in central nervous system plasticity after acute injury , 2014, Neuroscience.
[49] P. Basser,et al. Water Diffusion Changes in Wallerian Degeneration and Their Dependence on White Matter Architecture , 2000 .
[50] Damien Galanaud,et al. (1)H MR spectroscopy of human brain tumours: a practical approach. , 2008, European journal of radiology.
[51] A. Haley,et al. Dyslipidemia links obesity to early cerebral neurochemical alterations , 2013, Obesity.
[52] J Kim,et al. Imaging of the inflammatory response in reperfusion injury after transient cerebral ischemia in rats: correlation of superparamagnetic iron oxide-enhanced magnetic resonance imaging with histopathology , 2008, Acta radiologica.
[53] H. Rusinek,et al. MR spectroscopy indicates diffuse multiple sclerosis activity during remission , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[54] M. Cybulsky,et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.
[55] D. Arnold,et al. Dual‐temporal resolution dynamic contrast‐enhanced MRI protocol for blood–brain barrier permeability measurement in enhancing multiple sclerosis lesions , 2011, Journal of magnetic resonance imaging : JMRI.
[56] A. Vezzani,et al. In vivo imaging of glia activation using 1H‐magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity , 2012, Epilepsia.
[57] S. Hussain,et al. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.
[58] M. Viergever,et al. Magnetic Resonance Imaging of Monocytes Labeled with Ultrasmall Superparamagnetic Particles of Iron Oxide Using Magnetoelectroporation in an Animal Model of Multiple Sclerosis , 2010, Molecular imaging.
[59] A. van der Toorn,et al. Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis , 2010, NMR in biomedicine.
[60] Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain , 2013, Journal of Neuroimmune Pharmacology.
[61] Bruno Brochet,et al. Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE , 2006, NeuroImage.
[62] David J. Begley,et al. Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.
[63] K. J. Brooks,et al. Molecular Magnetic Resonance Imaging of Acute Vascular Cell Adhesion Molecule-1 Expression in a Mouse Model of Cerebral Ischemia , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[64] Martin Bendszus,et al. Cytokine profile of iron-laden macrophages: Implications for cellular magnetic resonance imaging , 2006, Journal of Neuroimmunology.
[65] D. Brooks,et al. Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation , 2012, Journal of viral hepatitis.
[66] M. Manns,et al. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. , 2004, Journal of hepatology.
[67] Olivier Beuf,et al. MRI Monitoring of Neuroinflammation in Mouse Focal Ischemia , 2007, Stroke.
[68] Axel Montagne,et al. Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders , 2012, NeuroImage.
[69] E. Neuwelt,et al. A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery. , 1999, AJNR. American journal of neuroradiology.
[70] N. Sibson,et al. Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease , 2009, Proceedings of the National Academy of Sciences.
[71] Ulrich Dirnagl,et al. Tracking of systemically administered mononuclear cells in the ischemic brain by high-field magnetic resonance imaging , 2006, NeuroImage.
[72] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[73] H. D. de Vries,et al. Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. , 2007, Radiology.
[74] H. Lanfermann,et al. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy , 2010, Gut.
[75] R. Dijkhuizen,et al. MRI of Monocyte Infiltration in an Animal Model of Neuroinflammation Using SPIO-Labeled Monocytes or Free USPIO , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[76] D. Häussinger,et al. Expression of organic osmolyte transporters in cultured rat astrocytes and rat and human cerebral cortex. , 2014, Archives of biochemistry and biophysics.
[77] Ralph Weissleder,et al. Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. , 2006, Radiology.
[78] John W. Chen,et al. A paramagnetic contrast agent with myeloperoxidase-sensing properties. , 2006, Organic & biomolecular chemistry.
[79] Ernst J. Rummeny,et al. Different Capacity of Monocyte Subsets to Phagocytose Iron-Oxide Nanoparticles , 2011, PloS one.
[80] Alan P Koretsky,et al. MRI detection of single particles for cellular imaging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[81] Diana Anderson. In Vitro Models , 1990, Drug safety.
[82] Marco Prinz,et al. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease , 2014, Nature Reviews Neuroscience.
[83] Xueguo Liu,et al. Magnetic resonance imaging of radiation-induced brain injury using targeted microparticles of iron oxide , 2012, Acta radiologica.
[84] Steven P Sourbron,et al. Classic models for dynamic contrast‐enhanced MRI , 2013, NMR in biomedicine.
[85] R. Ransohoff,et al. Development, maintenance and disruption of the blood-brain barrier , 2013, Nature Medicine.
[86] A. MacKay,et al. Is the magnetization transfer ratio a marker for myelin in multiple sclerosis? , 2011, Journal of magnetic resonance imaging : JMRI.
[87] A. McAllister,et al. Alterations in Immune Cells and Mediators in the Brain: It's Not Always Neuroinflammation! , 2014, Brain pathology.
[88] P. Jacobs,et al. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.
[89] P Kochunov,et al. Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation , 2015, Translational Psychiatry.
[90] P. Trouillas,et al. Inflammatory Response After Ischemic Stroke: A USPIO-Enhanced MRI Study in Patients , 2007, Stroke.
[91] Karen J. Ferguson,et al. Willis on narcolepsy , 2003, Journal of neurology, neurosurgery, and psychiatry.
[92] R. Weissleder,et al. Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging , 2011, Clinical Cancer Research.
[93] C. Robic,et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.
[94] Daniel Pelletier,et al. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. , 2005, Brain : a journal of neurology.
[95] Martin Bendszus,et al. in Vivo Monitoring of Macrophage Infiltration in Experimental Ischemic Brain Lesions by Magnetic Resonance Imaging , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[96] D. Vivien,et al. Ultra-Sensitive Molecular MRI of Vascular Cell Adhesion Molecule-1 Reveals a Dynamic Inflammatory Penumbra After Strokes , 2013, Stroke.
[97] Peter Mattsson,et al. Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1h magnetic resonance spectroscopy (MRS) study , 2010, Acta radiologica.
[98] G Tedeschi,et al. Brain atrophy and lesion load in a large population of patients with multiple sclerosis , 2005, Neurology.
[99] B. Rosen,et al. Evidence for brain glial activation in chronic pain patients. , 2015, Brain : a journal of neurology.
[100] C. A. Shaw,et al. In Vivo Mononuclear Cell Tracking Using Superparamagnetic Particles of Iron Oxide: Feasibility and Safety in Humans , 2012, Circulation Cardiovascular Imaging.
[101] Christian Confavreux,et al. Implementation of an Absolute Brain $^{1}$H-MRS Quantification Method to Assess Different Tissue Alterations in Multiple Sclerosis , 2012, IEEE Transactions on Biomedical Engineering.
[102] Bertrand Tavitian,et al. Noninvasive molecular imaging of neuroinflammation , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[103] David F Kallmes,et al. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. , 2015, Radiology.
[104] A. Haley,et al. Indirect Effects of Elevated Body Mass Index on Memory Performance Through Altered Cerebral Metabolite Concentrations , 2012, Psychosomatic medicine.
[105] N. Sibson,et al. Systemic Inflammatory Response Reactivates Immune-Mediated Lesions in Rat Brain , 2009, The Journal of Neuroscience.
[106] Ponnada A Narayana,et al. Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[107] Ralph Weissleder,et al. Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase , 2008, Proceedings of the National Academy of Sciences.
[108] M. Rausch,et al. MRI‐based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE , 2003, Magnetic resonance in medicine.
[109] R. Dijkhuizen,et al. MRI of ICAM-1 Upregulation After Stroke: the Importance of Choosing the Appropriate Target-Specific Particulate Contrast Agent , 2013, Molecular Imaging and Biology.
[110] Ofer Pasternak,et al. In vivo imaging of neuroinflammation in schizophrenia , 2016, Schizophrenia Research.
[111] Roland Martin,et al. Magnetic resonance imaging of labeled T‐cells in a mouse model of multiple sclerosis , 2004, Annals of neurology.
[112] Pascal J. Kieslich,et al. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. , 2015, Radiology.
[113] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[114] C. Woolf,et al. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology , 2012, Nature Neuroscience.
[115] Y. Anzai,et al. Blood-Brain Barrier Imaging and Therapeutic Potentials , 2006, Topics in magnetic resonance imaging : TMRI.
[116] C. Moonen,et al. Differential aquaporin 4 expression during edema build-up and resolution phases of brain inflammation , 2011, Journal of Neuroinflammation.
[117] J Hennig,et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. , 1994, Gastroenterology.
[118] R. Weissleder,et al. Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target. , 2012, Radiology.
[119] Assaf Tal,et al. Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS , 2013, Neurology.